Search Results - "Fernandez‐Penas, P."

Vitiligo‐like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers by Liu, R. C., Consuegra, G., Chou, S., Fernandez Peñas, P.

“…Summary Vitiligo‐like depigmentation (VLD) is a characteristic cutaneous event described in patients with metastatic malignant melanoma receiving treatment…”
Get full text

Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines by Lacouture, M.E., Sibaud, V., Gerber, P.A., van den Hurk, C., Fernández-Peñas, P., Santini, D., Jahn, F., Jordan, K.

“…•This ESMO Clinical Practice Guideline provides recommendations on the prevention/management of dermatological toxicities.•Authorship includes a…”
Get full text

Toxic epidermal necrolysis‐like lupus erythematosus: a condition to exclude in all patients with possible Stevens‐Johnson syndrome/toxic epidermal necrolysis by Truong, K., Goldinger, S., Kim, J., Smith, A., Fernandez‐Peñas, P.

Get full text

Successful treatment of highly refractory necrobiotic xanthogranuloma with peginterferon alfa‐2a by Truong, K., Venning, V., Wain, T., Chou, S., Fernandez‐Peñas, P.

Get full text

Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks by Anforth, R., Carlos, G., Clements, A., Kefford, R., Fernandez-Peñas, P.

“…Summary Background BRAF inhibitor‐based therapies have been shown to induce cutaneous toxicities, with onset generally in the first 8–26 weeks of therapy…”
Get full text

Patient perceptions of clear/almost clear skin in moderate‐to‐severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey by Armstrong, A., Jarvis, S., Boehncke, W.‐H., Rajagopalan, M., Fernández‐Peñas, P., Romiti, R., Bewley, A., Vaid, B., Huneault, L., Fox, T., Sodha, M., Warren, R.B.

“…Background Therapeutic advances have made the achievement of clear/almost clear skin possible for many patients with moderate‐to‐severe plaque psoriasis…”
Get full text

Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II by Thorlacius, L., Garg, A., Ingram, J.R., Villumsen, B., Theut Riis, P., Gottlieb, A.B., Merola, J.F., Dellavalle, R., Ardon, C., Baba, R., Bechara, F.G., Cohen, A.D., Daham, N., Davis, M., Emtestam, L., Fernández‐Peñas, P., Filippelli, M., Gibbons, A., Grant, T., Guilbault, S., Gulliver, S., Harris, C, Harvent, C., Houston, K., Kirby, J.S., Matusiak, L., Mehdizadeh, A., Mojica, T., Okun, M., Orgill, D., Pallack, L., Parks‐Miller, A., Prens, E.P., Randell, S., Rogers, C., Rosen, C.F., Choon, S.E., Zee, H.H., Christensen, R., Jemec, G.B.E.

“…Summary Background A core outcomes set (COS) is an agreed minimum set of outcomes that should be measured and reported in all clinical trials for a specific…”
Get full text

Incidence of cardiovascular events among tildrakizumab‐treated patients with moderate‐to‐severe plaque psoriasis: pooled data from three large randomised clinical trials by Bissonnette, R., Fernández‐Peñas, P., Puig, L., Mendelsohn, A.M., Rozzo, S.J., Menter, A.

Get full text

Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas by Grob, J.J., Gaudy‐Marqueste, C., Guminski, A., Malvehy, J., Basset‐seguin, N., Bertrand, B., Fernandez‐Penas, P., Kaufmann, R., Zalaudek, I., Fargnoli, M.C., Tagliaferri, L., Fertil, B., Del Marmol, V., Stratigos, A., Garbe, C., Peris, K.

“…Background No simple staging system has emerged for basal cell carcinomas (BCCs), since they do not follow the TNM process, and practitioners failed to agree…”
Get full text

Treatment-specific utility weightings are needed for cost-utility analysis in metastatic melanoma by Sebaratnam, D.F., Anforth, R., Fernández-Peñas, P.

Get full text

Real-world data on the efficacy and safety of hedgehog pathway inhibitors in patients with basal cell carcinoma: Experience of a tertiary Australian centre by Truong, K, Peera, M, Liu, R, Wijaya, M, Jones-Caballero, M, Araujo, R Ruiz, Fernandez-Penas, P

“…Basal cell carcinomas (BCCs) are the most common cancers worldwide. Although most BCCs are amenable to local treatment, there are limited therapeutic options…”
Get full text

Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors by Anforth, R., Blumetti, T.C.M.P., Clements, A., Kefford, R., Long, G.V., Fernandez-Peñas, P.

“…Summary Background The treatment of metastatic melanoma has changed greatly with the development of inhibitors targeted at the mutated BRAF kinase present in…”
Get full text

Experience of skin cancer and contact with health professionals is associated with increased skin cancer knowledge, but not sun safety knowledge or behaviour by Thomas, C.L., Fernandez‐Peñas, P.

Get full text

Pigmentary evolution with pembrolizumab use by Hwang, S.J.E., Fernandez‐Penas, P.

“…Linked Article: Wolner et al. Br J Dermatol 2018; 178:265–269…”
Get full text

Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition by Grob, J.J., Guminski, A., Malvehy, J., Basset‐seguin, N., Bertrand, B., Fernandez‐Penas, P., Kaufmann, R., Zalaudek, I., Gaudy‐Marqueste, C., Fargnoli, M.C., Tagliaferri, L., Fertil, B., Del Marmol, V., Stratigos, A., Garbe, C., Peris, K.

“…Background No simple classification system has emerged for ‘advanced basal cell carcinomas’, and more generally for all difficult‐to‐treat BCCs (DTT‐BCCs), due…”
Get full text

Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis by Fernandez-Peñas, P., Jones-Caballero, M., Espallardo, O., García-Díez, A.

“…Summary Background  Severity assessment of patients with psoriasis is a critical issue. Classical clinical assessment has recently been combined with quality…”
Get full text

Why do young adults tan? by Thomas, C.L., Peñas, P. Fernandez

Get full text

Risk Perception Plays Minimal Role in Sun Exposure Behaviours by Venning, V. L., Abbott, L. M., Thomas, C. L., Fernandez-Peñas, P.

“…Despite decades of public health campaigns, tanning and sunburn still occur at unacceptably high rates. Skin cancer prevention campaigns predominately focus on…”
Get full text

[Translated article] Nonvenereal Infections in Spanish Dermatology Clinics: Results of the DIADERM Study by Pulido-Pérez, A., Descalzo-Gallego, M.A., Arias-Santiago, S., Molina-Leyva, A., Gilaberte, Y., Fernández-Crehuet, P., Husein-ElAhmed, H., Viera-Ramírez, A., Fernández-Peñas, P., Taberner, R., Buendía-Eisman, A., García-Doval, I.

“…The burden of nonvenereal infections in Spanish dermatology practice has not yet been evaluated. The aim of this study was to analyze the overall weight of…”
Get full text

What Proportion of the Caseload at Dermatology Outpatient Clinics in Spain Do Skin Tumors Account for? Results from the DIADERM National Random Sampling Project by Martin-Gorgojo, A, Descalzo-Gallego, M Á, Arias-Santiago, S, Molina-Leyva, A, Gilaberte, Y, Fernández-Crehuet, P, Husein-ElAhmed, H, Viera-Ramírez, A, Fernández-Peñas, P, Taberner, R, Buendía-Eisman, A, García-Doval, I

“…INTRODUCTION AND OBJECTIVEA significant part of a dermatologist's activity involves the diagnosis and management of tumors. The aim of this study was to…”
Get full text